TCL Archive Four Center Grants In Danger; Shingleton to Retire, Owen Promoted At Hopkins January 9, 1987
TCL Archive Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials April 5, 1974
TCL Archive DCE Board Approves Two New Grant Programs, New Contract, Recompetitions Totaling $22 Mil. March 9, 1990
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
